Table 1 Distribution of repositories forming the pediatric leukemia single-cell atlas

From: Identification of leukemia-enriched signature through the development of a comprehensive pediatric single-cell atlas

 

EMORY

(N = 39)

GSE154109

(N = 19)

SCPCA

(N = 24)

TOTAL

(N = 82)

AML

20 (51.3%)

8 (42.1%)

20 (83.3%)

48 (58.5%)

Age At Presentation

 Mean (Range)

11.1 (1.5–17.8)

8.9 (1.6–15.9)

9.0 (0.6–15.2)

 

B-ALL

4 (10.3%)

7 (36.8%)

 

11 (13.4%)

Age At Presentation

 Mean (Range)

7.5 (2.3–17.4)

6.8 (3–15)

  

B/MY MPAL

3 (7.7%)

  

3 (3.7%)

Age At Presentation

 Mean (Range)

14.4 (13.7–15.1)

   

T/MY MPAL

2 (5.1%)

 

2 (8.3%)

4 (4.9%)

Age At Presentation

 Mean (Range)

10.4 (8.7–12.1)

 

12.9 (11.2–14.6)

 

T-ALL

10 (25.6%)

  

10 (12.2%)

Age At Presentation

 Mean (Range)

7.6 (1.7–16.5)

   

HEALTHY

 

4 (21.1%)

2 (8.3%)

6 (7.3%)

Donor Age

 N Age < 30 yrs.

 

4

2

 
  1. Disease group of single-cell RNA sequencing samples that were included in the pediatric leukemia atlas and healthy dataset analyses. Mean and range of ages for leukemia patients. Number of healthy donors with less than 30 years of age. See Supplementary Data 3 for specific sample, ages, and patient/donor information. Source data are provided as a Source Data file
Back to article page